The Think Tanks of the Pharmaceutical IndustryFor detailed information on the BioScience products as well as our online shop where orders can be placed, please go to our website http://www.gbo.com/bioscience
Research for the Future
Greiner Bio-One BioScience has specialists from the areas of biology, chemistry and physics working together on new products and solutions for the highly developed markets in Europe, Asia and USA. Headed by the Greiner Bio-One BioScience general manager Heinz Schmid, highly qualified research and development areas are directed from the central office in Frickenhausen, Germany. For future development as well as constant optimisation of existing solutions, the emphasis is on microstructure and nanostructure technology in order to guarantee highest possible efficiency in medicine and research from the expanding area of miniaturisation right up to biochip technology.
The vision: The innovative Greiner Bio-One BioScience product range should help people all over the world significantly increase their quality of life. The development of technologically demanding products in accordance with national and international requirements as well as the acquisition of new business areas creates successful company growth and provides users with an extra safety advantage. Greiner Bio-One BioScience also researches new solutions within the scope of a competence network made up of development partnerships, co-operations and shareholdings in other companies: shareholdings in the companies BioTeSys GmbH (76%), a full service provider for biological and chemical analyses on the basis of cellular substance detection, and Lambda GmbH (100%) for the development and production of biochips as well as co-operations with the Karlsruhe research institute and Hexal Gentech as well as various university research institutes contribute to continual progress and Greiner Bio-One BioScience’s growing market share.
From Pharmaceutical Substance Screening up to Use of Microarray in Diagnostics
Today, micro plates in standard format are indispensable for biochemical, medical and cell biology examinations. Micro plates are used in High Throughout Screening (HTS) as well as microarray technology, and protein crystallisation. As one of the leading suppliers of HTS products (High Throughput Screening) for pharmaceutical substance screening, Greiner Bio-One BioScience has the broadest range of micro plates on offer. All formats for use in fully automated systems are optimised. With a sample reservoir of either 96, 384, 1536 or 3456 wells per plate in addition to various materials and surface treatments, the products combine a high level of efficiency with precision and reliability.
One of the most recent Greiner Bio-One BioScience innovations is the HTA™ Platform. For the first time in professional diagnostic application, the design includes the functions of the micro plate. The platform is available in two formats: as an HTA™Slide – a plastic slide with 12 arrays, or as micro plate with 96 wells. Every array or well functions as an individual chip, so that either 12 or 96 individual arrays work parallel. This saves considerably on time, material and personnel expenditure when analyses are being carried out, thus simplifying and speeding up diagnostic research and development considerably.
For further information and our online shop, please go to: